OBI - ONDINE BIOMEDICAL - Share Chat

Ondine Biomedical Inc. (LSE: OBI) is a Canadian-headquartered life sciences company pioneering the development and commercialisation of its proprietary photodisinfection technologies. The company’s core innovation, Steriwave, is a light-activated antimicrobial solution designed for rapid, broad-spectrum pathogen eradication, primarily targeting the prevention of healthcare-associated infections (HAIs).

Steriwave is increasingly adopted for nasal decolonisation ahead of surgical procedures, reducing the risk of surgical site and bloodstream infections without contributing to antimicrobial resistance (AMR). By offering a non-antibiotic approach, Ondine’s technology helps healthcare systems improve patient safety, reduce healthcare costs, and combat the global threat of AMR. The company’s solutions are positioned to enhance infection control protocols across various medical settings.